Results 211 to 220 of about 82,077 (257)
Some of the next articles are maybe not open access.

Poxvirus Recombinant Vaccines

Annals of the New York Academy of Sciences, 1990
The poxvirus family, subfamily Chordopoxviridae, contains six genera. The basic criteria distinguishing membership in a genus is cross-neutralization and host-range predilection. Members of the genus Orthopoxvirus (vaccinia) and of the genus Avipoxvirus (fowlpox) have been genetically engineered to express genes from heterologous pathogens, thus ...
openaire   +2 more sources

Recombinant Vaccines

2023
Recombinant vaccines employ segments of genetic material from the target virus or bacterium. Unlike traditional vaccines, which often use weakened or inactivated pathogens, recombinant vaccines enable the immune system to recognize and respond to specific components of the pathogen, leading to a targeted and robust immune response.
openaire   +1 more source

Recombinant Adenoviruses as Vaccines

Biologicals, 1995
Over the past 15 years, advances in molecular biology have permitted in vitro and in vivo gene transfer into mammalian cells. Genetically engineered microorganisms are highly promising developments for gene therapy and the future of vaccines. Such vectors constitute genuine tools for high level expression of heterologous genes for both therapeutic and ...
V, Randrianarison-Jewtoukoff   +1 more
openaire   +2 more sources

Recombinant subunit vaccines

Current Opinion in Biotechnology, 1991
Research that may lead to the development of recombinant DNA-based vaccines has been conducted on a broad front. This has resulted in an increased understanding of immunological responsiveness to vaccines, the rational engineering of immunogens, and new means of delivering vaccines.
openaire   +2 more sources

Recombinant BCG Vaccine Candidates

Current Molecular Medicine, 2007
Given the variable protective efficacy provided by Mycobacterium bovis BCG (Bacillus Calmette-Guérin), there is a concerted effort worldwide to develop better vaccines that could be used to reduce the burden of tuberculosis. Recombinant BCG (rBCG) are vaccine candidates that offer some potential in this area.
Rogelio, Hernàndez-Pando   +3 more
openaire   +2 more sources

Nouveaux vaccins. Vaccins recombinants

Médecine et Maladies Infectieuses, 1987
Resume Les progres en biotechnologie et les techniques de recombinaison du DNA permettent d'envisager la creation de vaccins et l'amelioration de l'efficacite et de la securite d'emploi des vaccins actuels : - Les vaccins a virus vivants de demain sont obtenus a partir de virus chimeres crees par genie genetique. Introduire un gene etranger dans l'
openaire   +1 more source

Recombinant vaccines for poultry

Vaccine, 1991
The poultry industry relies on intensive farming to supply meat and eggs at relatively low cost. Many thousands of individuals are reared in enclosed houses which are left vacant for only short times between successive crops. Disease control is essential for the successful raising of poultry and this includes a need for cheap, effective vaccines ...
openaire   +2 more sources

Recombinant live virus vaccines

Immunology Letters, 1987
Many successful vaccines are based on live attenuated viruses. An attractive idea is to genetically engineer these live attenuated vaccines so that they express protective antigens from other pathogens. Vaccinia virus, the smallpox vaccine, can be considered as the prototype for this sort of approach.
openaire   +2 more sources

Recombinant vaccine delivery systems and encoded vaccines

Current Opinion in Immunology, 1994
In addition to the introductory demonstrations of genetic immunization, the past year has brought significant advances in vaccine development. Particularly encouraging are live recombinant vaccines, studies demonstrating the potential to elicit both systemic and mucosal immune responses, more studies demonstrating immune protection in animal disease ...
openaire   +2 more sources

Recombinant DNA Vaccines

1984
Of the many promises of the biotechnological revolution, none appear to offer more immediate application for improving the welfare of mankind than the biosynthesis by recombinant DNA (R-DNA) methods of vaccines for the diseases of humans and animals. Conventional vaccine development research for the production of both live and killed vaccines for human
Laurence A. Lasky, John F. Obijeski
openaire   +1 more source

Home - About - Disclaimer - Privacy